These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
169 related items for PubMed ID: 25355460
1. Strategies to maximize liposomal drug loading for a poorly water-soluble anticancer drug. Zhang W, Wang G, Falconer JR, Baguley BC, Shaw JP, Liu J, Xu H, See E, Sun J, Aa J, Wu Z. Pharm Res; 2015 Apr; 32(4):1451-61. PubMed ID: 25355460 [Abstract] [Full Text] [Related]
2. Physicochemical characterization of asulacrine towards the development of an anticancer liposomal formulation via active drug loading: stability, solubility, lipophilicity and ionization. See E, Zhang W, Liu J, Svirskis D, Baguley BC, Shaw JP, Wang G, Wu Z. Int J Pharm; 2014 Oct 01; 473(1-2):528-35. PubMed ID: 25079434 [Abstract] [Full Text] [Related]
3. Post-insertion of poloxamer 188 strengthened liposomal membrane and reduced drug irritancy and in vivo precipitation, superior to PEGylation. Zhang W, Wang G, See E, Shaw JP, Baguley BC, Liu J, Amirapu S, Wu Z. J Control Release; 2015 Apr 10; 203():161-9. PubMed ID: 25701612 [Abstract] [Full Text] [Related]
4. Novel sulfobutyl ether cyclodextrin gradient leads to highly active liposomal irinotecan formulation. Li C, Cui J, Wang C, Li Y, Zhang L, Xiu X, Li Y, Wei N, Zhang L, Wang P. J Pharm Pharmacol; 2011 Jun 10; 63(6):765-73. PubMed ID: 21585373 [Abstract] [Full Text] [Related]
5. Improving drug retention in liposomes by aging with the aid of glucose. Zhang W, Falconer JR, Baguley BC, Shaw JP, Kanamala M, Xu H, Wang G, Liu J, Wu Z. Int J Pharm; 2016 May 30; 505(1-2):194-203. PubMed ID: 27021465 [Abstract] [Full Text] [Related]
7. The influence of trapping agents on the antitumor efficacy of irinotecan liposomes: head-to-head comparison of ammonium sulfate, sulfobutylether-β-cyclodextrin and sucrose octasulfate. Yang W, Yang Z, Fu J, Guo M, Sun B, Wei W, Liu D, Liu H. Biomater Sci; 2018 Dec 18; 7(1):419-428. PubMed ID: 30500018 [Abstract] [Full Text] [Related]
10. Formulation and pharmacokinetic evaluation of an asulacrine nanocrystalline suspension for intravenous delivery. Ganta S, Paxton JW, Baguley BC, Garg S. Int J Pharm; 2009 Feb 09; 367(1-2):179-86. PubMed ID: 18848873 [Abstract] [Full Text] [Related]
11. Copper ion-mediated liposomal encapsulation of mitoxantrone: the role of anions in drug loading, retention and release. Li C, Cui J, Li Y, Wang C, Li Y, Zhang L, Zhang L, Guo W, Wang J, Zhang H, Hao Y, Wang Y. Eur J Pharm Sci; 2008 Aug 07; 34(4-5):333-44. PubMed ID: 18573336 [Abstract] [Full Text] [Related]
12. A novel oral delivery system consisting in "drug-in cyclodextrin-in nanostructured lipid carriers" for poorly water-soluble drug: vinpocetine. Lin C, Chen F, Ye T, Zhang L, Zhang W, Liu D, Xiong W, Yang X, Pan W. Int J Pharm; 2014 Apr 25; 465(1-2):90-6. PubMed ID: 24530388 [Abstract] [Full Text] [Related]
13. Inclusion complex of erlotinib with sulfobutyl ether-β-cyclodextrin: Preparation, characterization, in silico, in vitro and in vivo evaluation. Devasari N, Dora CP, Singh C, Paidi SR, Kumar V, Sobhia ME, Suresh S. Carbohydr Polym; 2015 Dec 10; 134():547-56. PubMed ID: 26428157 [Abstract] [Full Text] [Related]
14. Enhanced active liposomal loading of a poorly soluble ionizable drug using supersaturated drug solutions. Modi S, Xiang TX, Anderson BD. J Control Release; 2012 Sep 10; 162(2):330-9. PubMed ID: 22800581 [Abstract] [Full Text] [Related]